• Conference
  • Earn CE
  • Free Samples
  • Magazine
  • Subscribe
  • Videos
    • Recent Quotes
    My Watchlist
    Indicators
    Dental Market Index
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    Collegium Pharmaceutical, Inc. - Common Stock (NQ:COLL)

    45.10 -1.20 (-2.59%)
    Streaming Delayed Price Updated: 2:02 PM EST, Jan 2, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 153,469
    Open 46.33
    Bid (Size) 45.04 (100)
    Ask (Size) 45.15 (200)
    Prev. Close 46.30
    Today's Range 45.06 - 46.46
    52wk Range 23.23 - 50.79
    Shares Outstanding 32,250,236
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    Collegium Announces the Closing of $980 Million Syndicated Credit Facility
    Five-Year Financing with Favorable Terms that Significantly Reduce Interest Rate 
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    2 Reasons to Avoid COLL and 1 Stock to Buy Instead
    Collegium Pharmaceutical has been on fire lately. In the past six months alone, the company’s stock price has rocketed 68.7%, setting a new 52-week high of $49.89 per share. This was partly thanks to... 
    Via StockStory
    Topics Supply Chain

    Performance

    YTD
    N/A
    N/A
    1 Month
    -5.1%
    -5.1%
    3 Month
    +31.6%
    +31.6%
    6 Month
    +48.6%
    +48.6%
    1 Year
    +57.5%
    +57.5%

    More News

    Read More
    News headline image
    3 Cash-Producing Stocks We Think Twice About
    Via StockStory
    News headline image
    Earnings Scheduled For November 6, 2025 ↗
    Via Benzinga
    News headline image
    Collegium Pharmaceutical Inc (NASDAQ:COLL) Shows Strong Earnings Momentum and Bullish Technical Setup ↗
    Via Chartmill
    News headline image
    3 Unpopular Stocks We Find Risky
    Via StockStory
    News headline image
    Collegium Pharmaceutical Inc (NASDAQ:COLL) Fits the Minervini Growth Momentum Strategy ↗
    Via Chartmill
    News headline image
    Branded Pharmaceuticals Stocks Q3 Recap: Benchmarking Collegium Pharmaceutical (NASDAQ:COLL)
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    News headline image
    1 Growth Stock Set to Flourishand 2 Facing Challenges
    Via StockStory
    News headline image
    1 Mooning Stock with Promising Prospects and 2 Facing Challenges
    Via StockStory
    News headline image
    1 Small-Cap Stock with Exciting Potential and 2 We Avoid
    Via StockStory
    News headline image
    Branded Pharmaceuticals Stocks Q3 Earnings: Eli Lilly (NYSE:LLY) Best of the Bunch
    Via StockStory
    Topics Artificial Intelligence Intellectual Property
    News headline image
    Collegium Pharmaceutical Inc (NASDAQ:COLL) Shows High Growth Momentum with Strong Technicals ↗
    Via Chartmill
    News headline image
    5 Revealing Analyst Questions From Collegium Pharmaceutical’s Q3 Earnings Call
    Via StockStory
    Topics Earnings
    News headline image
    1 Safe-and-Steady Stock with Competitive Advantages and 2 We Brush Off
    Via StockStory
    News headline image
    Collegium to Participate in Upcoming Investor Conferences
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    2 Momentum Stocks with Exciting Potential and 1 We Find Risky
    Via StockStory
    Topics Credit Cards
    News headline image
    COLL Q3 Deep Dive: Jornay PM Momentum and Pain Portfolio Drive Upgraded Outlook
    Via StockStory
    News headline image
    Why Are Collegium Pharmaceutical (COLL) Shares Soaring Today
    Via StockStory
    Topics Economy Government World Trade
    News headline image
    Collegium Pharmaceutical Inc (NASDAQ:COLL) Beats Q3 2025 Estimates and Raises Full-Year Guidance ↗
    Via Chartmill
    News headline image
    Collegium Pharmaceutical (NASDAQ:COLL) Delivers Impressive Q3, Stock Jumps 12.1%
    Via StockStory
    News headline image
    Collegium Reports Third Quarter 2025 Financial Results; Raises 2025 Guidance
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire
    News headline image
    Earnings To Watch: Collegium Pharmaceutical (COLL) Reports Q3 Results Tomorrow
    Via StockStory
    News headline image
    3 Stocks Under $50 That Fall Short
    Via StockStory
    Topics Artificial Intelligence
    News headline image
    Paris Hilton Collaborates with Collegium Pharmaceutical to Share Her Personal ADHD Journey and Experience with Treatment
    From Collegium Pharmaceutical, Inc.
    Via GlobeNewswire

    Frequently Asked Questions

    Is Collegium Pharmaceutical, Inc. - Common Stock publicly traded?
    Yes, Collegium Pharmaceutical, Inc. - Common Stock is publicly traded.
    What exchange does Collegium Pharmaceutical, Inc. - Common Stock trade on?
    Collegium Pharmaceutical, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock?
    The ticker symbol for Collegium Pharmaceutical, Inc. - Common Stock is COLL on the Nasdaq Stock Market
    What is the current price of Collegium Pharmaceutical, Inc. - Common Stock?
    The current price of Collegium Pharmaceutical, Inc. - Common Stock is 45.10
    When was Collegium Pharmaceutical, Inc. - Common Stock last traded?
    The last trade of Collegium Pharmaceutical, Inc. - Common Stock was at 01/02/26 02:02 PM ET
    What is the market capitalization of Collegium Pharmaceutical, Inc. - Common Stock?
    The market capitalization of Collegium Pharmaceutical, Inc. - Common Stock is 1.45B
    How many shares of Collegium Pharmaceutical, Inc. - Common Stock are outstanding?
    Collegium Pharmaceutical, Inc. - Common Stock has 1B shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.